S Mattheis1, B Kansy2, P Haßkamp2, L Holtmann2, S Lang2. 1. Klinik für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie Universitätsklinikum Essen, Hufelandstr. 55, 45122, Essen, Deutschland. stefan.mattheis@uk-essen.de. 2. Klinik für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie Universitätsklinikum Essen, Hufelandstr. 55, 45122, Essen, Deutschland.
Abstract
BACKGROUND: The role of transoral robotic surgery (TORS) in the treatment of head and neck tumors has expanded in the last decade. OBJECTIVES: We present the development and current advances in TORS along with the current indications and contraindications, and describe future developments. METHODS: We present our own studies and review those in the literature. RESULTS: Since approval of the da Vinci® system, the number of TORS cases has increased significantly. The main indications are tumors of the oropharynx and supraglottis. Most published studies are retrospective case series with no control group. In addition to the further development of the da Vinci® system, the introduction of the Flex®-system is a significant progression. The costs of using robotic systems are high. CONCLUSIONS: Technical improvement of robotic systems and the development of new surgical techniques will further expand the indications for TORS. The value of TORS needs to be assessed in prospective controlled studies.
BACKGROUND: The role of transoral robotic surgery (TORS) in the treatment of head and neck tumors has expanded in the last decade. OBJECTIVES: We present the development and current advances in TORS along with the current indications and contraindications, and describe future developments. METHODS: We present our own studies and review those in the literature. RESULTS: Since approval of the da Vinci® system, the number of TORS cases has increased significantly. The main indications are tumors of the oropharynx and supraglottis. Most published studies are retrospective case series with no control group. In addition to the further development of the da Vinci® system, the introduction of the Flex®-system is a significant progression. The costs of using robotic systems are high. CONCLUSIONS: Technical improvement of robotic systems and the development of new surgical techniques will further expand the indications for TORS. The value of TORS needs to be assessed in prospective controlled studies.
Entities:
Keywords:
Head and neck cancer; Microsurgery; Oropharynx; Robotics; Surgical endoscopy
Authors: Brian M Haus; Neeraja Kambham; David Le; Frederic M Moll; Christine Gourin; David J Terris Journal: Laryngoscope Date: 2003-07 Impact factor: 3.325
Authors: Georges Lawson; Abie H Mendelsohn; Sebastien Van Der Vorst; Vincent Bachy; Marc Remacle Journal: Laryngoscope Date: 2012-04-20 Impact factor: 3.325
Authors: Erik Liederbach; Carol M Lewis; Katharine Yao; Bruce E Brockstein; Chi-Hsiung Wang; Waseem Lutfi; Mihir K Bhayani Journal: Ann Surg Oncol Date: 2015-04-17 Impact factor: 5.344
Authors: Yogesh I More; Terance T Tsue; Douglas A Girod; John Harbison; Kevin J Sykes; Carson Williams; Yelizaveta Shnayder Journal: JAMA Otolaryngol Head Neck Surg Date: 2013-01 Impact factor: 6.223
Authors: Vikas Mehta; Paul Johnson; Andrew Tassler; Seungwon Kim; Robert L Ferris; Melonie Nance; Jonas T Johnson; Umamaheswar Duvvuri Journal: Laryngoscope Date: 2012-11-14 Impact factor: 3.325
Authors: B Lallemant; S Moriniere; P Ceruse; M Lebalch; K Aubry; S Hans; G Dolivet; O Malard; Q Bonduelle; S Vergez Journal: Eur Arch Otorhinolaryngol Date: 2017-10-14 Impact factor: 2.503